π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This is a phase 3, multicenter, double-blind, placebo-controlled, randomize...
Status
Completed
Location
Peking University First Hospital
Start Date
2023-09-14
Trial ID
NCT06076486
Treatments Being Tested
Uterine Fibroids (UF) are benign smooth muscle neoplasms of the uterus that...
Status
Withdrawn
Location
Dorsata /ID# 252675
Start Date
2023-12-20
Trial ID
NCT06058728
The purpose of this study is twofold: First, to see if elagolix can suppres...
Status
Unknown
Location
Multiple Locations
Start Date
2019-10-01
Trial ID
NCT04060992
Treatments Being Tested
The main objective of this study is to assess safety and efficacy of elagol...
Status
Completed
Location
ACCEL Research Sites /ID# 209714
Start Date
2019-04-12
Trial ID
NCT03886220
Endometriosis is an abnormal, estrogen-dependent growth of endometrial tiss...
Status
Completed
Location
Meir Medical Center /ID# 224766
Start Date
2020-12-14
Trial ID
NCT04630990
This is a Phase 2b randomized, double-blind, placebo-controlled study evalu...
Status
Completed
Location
Multiple Locations
Start Date
2013-04-08
Trial ID
NCT01817530
The purpose of this study is to evaluate elagolix (NBI-56418) compared to p...
Status
Completed
Location
Multiple Locations
Start Date
2009-10-12
Trial ID
NCT00973973
Uterine Fibroids (UF) are noncancerous (benign) tumors that commonly occur ...
Status
Terminated
Location
IQVIA RDS, Inc.
Start Date
2021-10-05
Trial ID
NCT05026502
Twenty-six otherwise healthy adults between 18-40 years of age composed of ...
Status
Completed
Location
University of Wisconsin
Start Date
2024-07-24
Trial ID
NCT06253702
Treatments Being Tested